We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 1,524

Brexit - Implications for regulation of financial services
  • Hogan Lovells
  • European Union, United Kingdom
  • May 12 2016

A referendum will be held in the UK on 23 June 2016 to determine whether the UK should remain in the European Union (EU) or leave It. The UK


Why Brexit Will Not Happen (In Data Protection)
  • Hogan Lovells
  • European Union, United Kingdom
  • May 25 2016

The thing about referendums is that the consequences of one outcome or another are likely to be rather disparate. If Brexit turns out to be rejected


Brexit First Aid for Pharma
  • Hogan Lovells
  • European Union, United Kingdom
  • May 24 2016

Should the UK choose to leave the EU, there will be a substantial impact for the UK pharmaceutical industry. Crucially, these implications will not


3 considerations, ahead of the start of the Unitary Patent Court (UPC)
  • Hogan Lovells
  • European Union, United Kingdom
  • May 26 2016

So, the UPC is coming in 2017. Patent owners have considered which of their crown-jewel European patents to opt-out of the system during the


DSM Watch: European Commission releases key digital market proposals
  • Hogan Lovells
  • European Union
  • May 25 2016

The European Commission today released five long-awaited digital market proposals: The draft amendment to Europe’s Audiovisual Media Services


Ten VAT things you need to know about Brexit
  • Hogan Lovells
  • European Union, United Kingdom
  • May 12 2016

EU VAT Directives will no longer apply to it. But it is unlikely to do that (at least without replacing it with a similar tax) as it raises so much


Medical Device Alert - Political Agreement Concerning the Text of the new Regulations on medical devices and in vitro diagnostic medical devices
  • Hogan Lovells
  • European Union
  • May 26 2016

Late on 25 May 2016, the Council of the European Union issued a press release to announce that the European Commission, the European Parliament and


New rules on payment terms
  • Hogan Lovells
  • European Union
  • May 2 2013

New rules which control the payment terms in most contracts involving European Union businesses are now in force. This note summarises the effect of


EU merger control complications for Chinese SOE transactions
  • Hogan Lovells
  • European Union
  • May 24 2016

The European Commission recently published its decision clearing the joint acquisition by Electricité de France S.A. (EDF) and China General Nuclear


ESMA publishes updated Prospectus Q&A
  • Hogan Lovells
  • European Union
  • May 11 2016

The European Securities and Markets Authority (ESMA) has published an updated version of its Questions and Answers (Q&A) document on prospectus